Hello and welcome to the details of Operation Warp Speed to start making Covid-19 vaccine by end of summer, says US official and now with the details
WASHINGTON, July 14 — Drugmakers partnered with the US government are on track to begin actively manufacturing a vaccine for Covid-19 by the end of the summer, a senior administration official said yesterday.
“If you say exactly when will literally the vaccine materials be in production and manufacturing, it is probably four to six weeks away, but we will be actively manufacturing by the end of summer,” the official said.
He added that the administration is already working with companies to equip and outfit manufacturing facilities and acquire raw materials.
The Trump administration has helped finance the development of four Covid-19 vaccines so far though its Operation Warp Speed Programme.
So far, the US government has given grants ranging from several hundred million dollars to over US$1 billion (RM 1.26 billion) to companies including Johnson & Johnson, Moderna Inc, AstraZeneca Plc and Novovax Inc.
It has also signed a US$450 million contract with last month with Regeneron Pharmaceuticals Inc to help it supply therapies for patients who are sick with the virus.
The “slate is not closed” for additional funding agreements and the administration plans to announce more in the future, the senior administration official said. — Reuters
These were the details of the news Operation Warp Speed to start making Covid-19 vaccine by end of summer, says US official for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
